secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2021-07-22T23:59:59+00:00
Accession:  0001628280-21-014235
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology reports record FY2021 revenue of $41M (+28% YoY); turns to operating profit of $338K
--------------------------------------------------------------------------------

- FY2021 revenue $41.0M, up 28% from $32.1M; Q4 revenue $10.6M, up 21% from $8.8M.
- Full-year operating income of $338K vs loss of $1.9M; Q4 operating loss narrowed to $456K from $2.0M.
- Gross margin improved to 48% (FY2021) and 47% (Q4) vs 47% and 43% a year ago.
- Cash position $4.7M with no debt; net cash used in ops $1.7M for the year.
- Launched Lumin SaaS platform; developing AI/ML-driven target discovery using proprietary datasets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828021014235/0001628280-21-014235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828021014235/csbr-20210722.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-014235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer